Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Putting pharmacogenetics into practice.

Michael M Hopkins1, Dolores Ibarreta, Sibylle Gaisser

  • 1Science and Technology Policy Research, The Freeman Centre, University of Sussex, Brighton BN1 9QE, UK. m.m.hopkins@sussex.ac.uk

Nature Biotechnology
|April 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discordance in orphan drug approvals between the U.S. Food and Drug Administration and the European Medicines Agency: A retrospective observational analysis.

PLoS medicine·2026
Same author

Spatial role of land cover on West Nile virus disease in Europe.

iScience·2026
Same author

Preference-based measures in people with dementia: a systematic review of psychometric properties.

Health and quality of life outcomes·2026
Same author

Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review.

PharmacoEconomics·2026
Same author

The Economics of Group Antenatal Care: A Systematic Review and Narrative Analysis.

Maternal and child health journal·2026
Same author

Policy challenges in the provision of COVID-19 border screening: evidence from eight countries.

BMC public health·2026
Same journal

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Nature biotechnology·2026
Same journal

Quantum computing in transition.

Nature biotechnology·2026
Same journal

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Nature biotechnology·2026
Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
See all related articles

Genetics helps explain why people respond differently to drugs. Implementing supportive policies for research, regulation, and education is crucial for using this genetic knowledge effectively.

Area of Science:

  • Pharmacogenomics
  • Translational Medicine
  • Health Policy

Background:

  • Genetic variations influence individual responses to medications.
  • Current application of pharmacogenomic data in clinical practice is limited.
  • Translational research requires robust policy frameworks for sustained progress.

Purpose of the Study:

  • To highlight the role of genetics in drug response.
  • To emphasize the necessity of supportive policies for advancing pharmacogenomics.
  • To outline key areas requiring policy intervention.

Main Methods:

  • Review of current literature on pharmacogenomics and drug response.
  • Analysis of policy requirements for translational research.
  • Identification of educational and regulatory needs.

Related Experiment Videos

Main Results:

  • Genetics offers insights into drug response variability.
  • Policy implementation is essential for translating genetic discoveries into clinical practice.
  • Long-term support is needed across research, regulation, and education.

Conclusions:

  • Genomic insights into drug response are emerging.
  • Effective policy is paramount for the successful integration of pharmacogenomics.
  • Sustained investment in translational research, regulatory adaptation, and professional education is vital.